Baxter International Inc. vs. InfuSystem Holdings, Inc.
Baxter International Inc. and InfuSystem Holdings, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BAX | INFU | |
|---|---|---|
| Market Cap | $13.96 billion | $248.77 million |
| Revenue (TTM) | $11.47 billion | $143.34 million |
| Net Income (TTM) | $-1,063,000,000 | $8.54 million |
BAX leads on 2 of 3 size & scale factors.
Valuation
| BAX | INFU | |
|---|---|---|
| P/E Ratio | — | 31.22 |
| Price / Book | 2.26 | 4.21 |
| Price / Sales | 1.22 | 1.74 |
BAX leads on 2 of 2 valuation factors.
Profitability
| BAX | INFU | |
|---|---|---|
| Net Margin | -9.27% | 5.96% |
| Return on Equity | -17.20% | 14.44% |
INFU leads on 2 of 2 profitability factors.
Dividend
| BAX | INFU | |
|---|---|---|
| Dividend Yield | 0.15% | — |
BAX and INFU split the dividend factors evenly.
Risk & Sentiment
| BAX | INFU | |
|---|---|---|
| Short Interest | 1.03% | 0.02% |
INFU leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, INFU overview, INFU financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.